Entopsis

About:

Entopsis is a developer of novel biomedical products that allows for direct PCR from clinical samples.

Twitter/X: entopsis

Description:

Entopsis is a privately held company developing novel biomedical products for research and clinical use, predominantly in the areas of oncology, autoimmune disorders, metabolic disorders, and developing world malignancies. The company has established various strategic industry and academic research collaborations geared towards advancing company goals. It was incorporated in 2011 and is headquartered in Hialeah, Florida.

Total Funding Amount:

$2.42M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hialeah, Florida, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)entopsis.com

Founders:

Ian Cheong, Obdulio Piloto

Number of Employees:

1-10

Last Funding Date:

2021-03-01

IPO Status:

Private

Industries: